Studies related to Hematocrit and Curcumin

The Effectiveness Of Fermented Turmeric Powder In Subjects With Elevated Alanine Transaminase Levels: A Randomised Controlled Study

Effect None
Values (%). Placebo: before 44.8 ± 2.9, after 45.4 ± 3. Turmeric: before 45.9 ± 2.9, after 46.0 ± 3.4
Trial Design Randomized trial
Trial Length 2-4 Weeks
Number of Subjects 60
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 60 participants with elevated liver enzymes were allocated to take 3 g of fermented turmeric powder (2.37 mg curcumin) or placebo daily for 12 weeks.

ALT was the primary outcome, and the curcumin group saw a statistically significant reduction compared with the placebo group. AST was also significantly reduced but ALP, gamma-GT, and bilirubin were not.

There were no statistically significant differences between groups for total cholesterol, triglycerides, HDL-C, LDL- C, fasting glucose, total protein in serum, albumin, BUN, creatine, white blood cell count, red blood cell count, hemoglobin, hematocrit, or platelet count.